scholarly article | Q13442814 |
P50 | author | Andrew C Emery | Q57007602 |
Hannah A Hathaway | Q57008862 | ||
P2093 | author name string | Jarda T Wroblewski | |
Tara Gelb | |||
Ewa Grajkowska | |||
Sergey Pshenichkin | |||
Barry B Wolfe | |||
P2860 | cites work | Disruption of metabotropic glutamate receptor signalling is a major defect at cerebellar parallel fibre-Purkinje cell synapses in staggerer mutant mice. | Q45729180 |
Identification of indole derivatives exclusively interfering with a G protein-independent signaling pathway of the prostaglandin D2 receptor CRTH2. | Q46471412 | ||
Characterization and distribution of the neuronal glutamate transporter EAAC1 in rat brain | Q48066974 | ||
Cloning, expression, and gene structure of a G protein-coupled glutamate receptor from rat brain | Q48224778 | ||
The metabotropic glutamate receptor 1, GRM1: evaluation as a candidate gene for inherited forms of cerebellar ataxia. | Q50271229 | ||
The role of depolarization in the survival and differentiation of cerebellar granule cells in culture. | Q51789112 | ||
Activation of metabotropic glutamate receptors prevents neuronal apoptosis in culture. | Q52211395 | ||
What is pharmacological 'affinity'? Relevance to biased agonism and antagonism. | Q53149817 | ||
N-methyl-D-aspartate promotes the survival of cerebellar granule cells in culture | Q69929483 | ||
3,5-dihydroxyphenylglycine is a highly selective agonist for phosphoinositide-linked metabotropic glutamate receptors in the rat hippocampus | Q72069910 | ||
Temporal and depolarization-induced changes in the absolute amounts of mRNAs encoding metabotropic glutamate receptors in cerebellar granule neurons in vitro | Q72728960 | ||
Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 | ||
Sequence and expression of a metabotropic glutamate receptor | Q28280066 | ||
Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma | Q28290954 | ||
CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding | Q28370513 | ||
Molecular diversity of glutamate receptors and implications for brain function | Q28611078 | ||
Beta-arrestins and cell signaling | Q29616793 | ||
Pharmacology and functions of metabotropic glutamate receptors | Q29619150 | ||
Metabotropic glutamate receptors: from the workbench to the bedside | Q30448778 | ||
Activation of the glutamate receptor GRM1 enhances angiogenic signaling to drive melanoma progression | Q33560677 | ||
Divergent transducer-specific molecular efficacies generate biased agonism at a G protein-coupled receptor (GPCR) | Q33619504 | ||
Beyond desensitization: physiological relevance of arrestin-dependent signaling. | Q33890802 | ||
Teaching old receptors new tricks: biasing seven-transmembrane receptors | Q33985759 | ||
The protective signaling of metabotropic glutamate receptor 1 Is mediated by sustained, beta-arrestin-1-dependent ERK phosphorylation. | Q34074283 | ||
JNJ16259685, a highly potent, selective and systemically active mGlu1 receptor antagonist | Q34369735 | ||
Cerebellar granule cells as a model to study mechanisms of neuronal apoptosis or survival in vivo and in vitro | Q35184527 | ||
Quantifying ligand bias at seven-transmembrane receptors. | Q35188090 | ||
A negative allosteric modulator demonstrates biased antagonism of the follicle stimulating hormone receptor | Q35817527 | ||
Ligand bias at metabotropic glutamate 1a receptors: molecular determinants that distinguish β-arrestin-mediated from G protein-mediated signaling. | Q36105482 | ||
Functional effects of GRM1 suppression in human melanoma cells | Q36409682 | ||
Autosomal-recessive congenital cerebellar ataxia is caused by mutations in metabotropic glutamate receptor 1. | Q36439309 | ||
Molecular mechanism of β-arrestin-biased agonism at seven-transmembrane receptors | Q36773326 | ||
Dual neurotoxic and neuroprotective role of metabotropic glutamate receptor 1 in conditions of trophic deprivation - possible role as a dependence receptor | Q37021962 | ||
The origins of diversity and specificity in g protein-coupled receptor signaling | Q37131419 | ||
Metabotropic glutamate 1 receptor: current concepts and perspectives. | Q37359380 | ||
Metabotropic glutamate receptors in neurodegeneration/neuroprotection: still a hot topic? | Q37981470 | ||
Biased ligands at G-protein-coupled receptors: promise and progress | Q38216119 | ||
Ras protein activation is a key event in activity-dependent survival of cerebellar granule neurons. | Q38383460 | ||
Metabotropic glutamate receptor 1 acts as a dependence receptor creating a requirement for glutamate to sustain the viability and growth of human melanomas | Q38971337 | ||
Cell type-specific differences in the coupling of recombinant mGlu1alpha receptors to endogenous G protein sub-populations | Q40811646 | ||
Characterization of metabotropic glutamate receptor-stimulated phosphoinositide hydrolysis in rat cultured cerebellar granule cells. | Q41931681 | ||
Pharmacological enhancement of mGlu1 metabotropic glutamate receptors causes a prolonged symptomatic benefit in a mouse model of spinocerebellar ataxia type 1. | Q42264500 | ||
Different coupling of excitatory amino acid receptors with Ca2+ channels in primary cultures of cerebellar granule cells | Q43783951 | ||
L-homocysteine sulfinic acid and other acidic homocysteine derivatives are potent and selective metabotropic glutamate receptor agonists. | Q44370393 | ||
P1104 | number of pages | 10 | |
P304 | page(s) | 199-208 | |
P577 | publication date | 2015-02-17 | |
P1433 | published in | Neuropharmacology | Q15332439 |
P1476 | title | Pharmacological characterization of mGlu1 receptors in cerebellar granule cells reveals biased agonism | |
P478 | volume | 93 |
Q47865915 | Biased allosteric agonism and modulation of metabotropic glutamate receptor 5: Implications for optimizing preclinical neuroscience drug discovery |
Q46083239 | Control of neuronal excitability by Group I metabotropic glutamate receptors |
Q91581400 | Kinetic and system bias as drivers of metabotropic glutamate receptor 5 allosteric modulator pharmacology |
Q59335641 | Metabotropic Glutamate Receptors in Glial Cells: A New Potential Target for Neuroprotection? |
Q38567309 | Metabotropic glutamate receptor subtype 5: molecular pharmacology, allosteric modulation and stimulus bias |
Q37464855 | Transduction of group I mGluR-mediated synaptic plasticity by β-arrestin2 signalling |
Q33562835 | β-Arrestin2 Couples Metabotropic Glutamate Receptor 5 to Neuronal Protein Synthesis and Is a Potential Target to Treat Fragile X. |
Search more.